Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Top 3 Growth Opportunities for Digital Pathology-enabling Technology Companies 2019-02-26 03:13
Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG 2019-02-25 22:00
Innovent Organized a Forum Discussing the Pending Launch of its Anti PD-1 Tyvyt® (Sintilimab injection) as Part of the National Mega Innovation Program in Beijing 2019-02-22 15:02
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi™ (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU 2019-02-22 06:13
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics 2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics 2019-02-19 08:21
Innovent Announces a Collaboration with Chipscreen Biosciences to Evaluate the Combination Therapy in Colorectal Cancer Patients 2019-02-18 08:00
Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine 2019-02-18 07:48
Avapritinib receives Phase III clinical trial approval for GIST in China 2019-02-15 23:19
Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens' FibroScan® 2019-02-14 20:02
Singapore Health Sciences Authority Approves Biktarvy(R) (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection 2019-02-14 17:09
SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe 2019-02-14 16:00
Frost & Sullivan Publishes Q1 2019 Update on Oramed Pharmaceuticals Inc. 2019-02-14 03:01
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing 2019-02-13 08:00
Frost & Sullivan Publishes Immediate Report on BiolineRx 2019-02-13 01:17
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership 2019-02-12 08:04
3SBio and Verseau Establish Global Clinical Development Collaboration for First-in-class Immuno-Oncology Therapies 2019-02-11 20:19
BioLineRx Announces Closing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants 2019-02-08 02:42
Innovent Receives IND Approval of a Bispecific Antibody (IBI318) by the NMPA 2019-02-07 22:37
1 201 202 203 204 205 247